Keystone Symposia “Malaria: Confronting Challenges from Drug Discovery to Treatment” – 2022

Date:

April 11, 2022 — April 13, 2022

Country:

United States

Author(s):

MESA

This report is brought to you by the MESA Correspondents Patricia Doumbe Belisse, Nutpakal Ketprasit, and Samuel Blankson. Senior editorial support has been facilitated by the Chairs and Speakers of the session.

The Keystone Symposia Meeting on ‘Malaria: Confronting Challenges From Drug Discovery to Treatment’ held in Breckenridge, CO, USA, from Apr 10-13, 2022, addressed the pressing need to accelerate the development of new antimalarials that can treat Plasmodium falciparum parasites that have acquired resistance to existing first-line drugs.

The specific aims of the event were:

  • Review recent innovations in antimalarial drug discovery
  • Examine preclinical and clinical models to test compounds in development
  • Review the efficacy of ACTs across different endemic settings and discuss current approaches to reducing the disease burden
  • Review the current status of antimalarial resistance, including mechanistic studies and how they inform our understanding of drug modes of action
  • Discuss new medicines, and prophylaxis, treatment and transmission-blocking strategies.

Reports

Last Updated: 30/04/2025

This report is brought to you by the MESA Correspondents Patricia Doumbe Belisse, Nutpakal Ketprasit, and Samuel Blankson. Senior editorial support has been facilitated by the Chairs and Speakers of the session.

SHARE